SCHEMBL24944990

SCHEMBL24944990

CN1CCN(Cc2ccc(Nc3nc(C4CC4)c(-c4cncc5c4ncn5C)nc3C(N)=O)cc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKE Q14164 7/20 0.44
▸ TBK1 Q9UHD2 7/20 0.44
▸ FLT3 P36888 2/20 0.39
▸ EGFR P00533 1/20 0.39
▸ AXL P30530 2/20 0.38
▸ SYK P43405 1/20 0.38
▸ EML4 Q9HC35 3/20 0.38
▸ ALK Q9UM73 3/20 0.38
▸ RET P07949 1/20 0.38
▸ ROS1 P08922 1/20 0.38
▸ TNIK Q9UKE5 1/20 0.37
▸ CCNT1 O60563 1/20 0.37
▸ CDK4 P11802 1/20 0.37
▸ CCND1 P24385 1/20 0.37
▸ CDK9 P50750 1/20 0.37
▸ CDK6 Q00534 1/20 0.37
▸ CDK11A Q9UQ88 1/20 0.37
▸ MAP3K11 Q16584 1/20 0.37
▸ MELK Q14680 1/20 0.37
▸ AURKA O14965 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30205756 1.00 IKBKE (0.44) IKBKETBK1FLT3EGFRAXL
SCHEMBL24944456 0.95 IKBKE (0.38) IKBKETBK1FLT3EGFRSYK
SCHEMBL30205520 0.95 IKBKE (0.38) IKBKETBK1FLT3EGFRSYK
SCHEMBL29173673 0.92 FLT3 (0.39) IKBKETBK1FLT3AXLMELK
SCHEMBL30205589 0.89 IKBKE (0.46) IKBKETBK1FLT3AXLSYK
SCHEMBL24943840 0.89 IKBKE (0.46) IKBKETBK1FLT3AXLSYK
SCHEMBL24944440 0.88 IKBKE (0.44) IKBKETBK1AXLALKTNIK
SCHEMBL30205592 0.88 IKBKE (0.44) IKBKETBK1AXLALKTNIK
SCHEMBL24943838 0.87 TBK1 (0.46) IKBKETBK1FLT3AXLEML4
SCHEMBL30205580 0.87 TBK1 (0.46) IKBKETBK1FLT3AXLEML4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117693503-A Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer 阿斯利康(瑞典)有限公司 2024-03-12 — — CN claimed
CN-117693503-A Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer 阿斯利康(瑞典)有限公司 2024-03-12 — — CN disclosed
WO-2023001794-A1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2023-01-26 — — WO disclosed
Send feedback